Marsh & McLennan Companies, Inc.

▲ Bull Case

• ◆McGriff delivers long-duration growth platform: ~$2-3B revenue base growing 8-10%/yr contributes $160-300M+ new annual revenue, more than historical organic growth; cross-selling risk advisory into construction, healthcare, real estate client bases unlocks channel MMC previously lacked; by FY2028 could be $3.5-4B segment at 30%+ margins = $1B+ operating income, driving adj. EPS to $14.00 (~$378/share at 27x).
• ◆Thrive program exceeds $400M target by FY2027: Operational restructuring from McGriff/MMA integration scale benefits; if delivering $500M (25% beat), EPS contribution reaches $0.80-1.00/share vs. $0.65 base case; combined with organic growth, adj. EPS of $14+ in FY2028 justifies premium multiple convergence with AJG.
• ◆Insurance pricing re-hardens after major CAT event: Significant hurricane season or casualty reserve deterioration could push commercial P&C pricing up 8-12%, adding 2-3pp to Marsh organic growth; at MMC's scale, every 1pp additional organic growth = ~$130M revenue = ~$0.18-0.20/share adj. EPS.

▼ Bear Case

• ◆McGriff retention underperforms: AJG, AON/NFP, and regional independents competing for relationships; if broker retention falls to 85% vs. 92%, MMC loses $300-450M of expected revenue run-rate; combined with $549M/yr amortization drag, adj. EPS compresses to $9.50 at 20x = $190 (-19% from $235).
• ◆Fed cuts aggressively; fiduciary income falls $200M: If Fed cuts 6+ times in 2025-2026, fiduciary income falls from $497M to ~$300M = $0.30/share EPS drag; combined with below-consensus organic growth, adj. EPS misses FY2026 consensus and stock de-rates to 21-22x.
• ◆Oliver Wyman consulting cycle turns: Management consulting cyclically sensitive (OW fell ~20% in 2009); in mild recession -10% YoY revenue = -$200-300M, -$50-75M operating income, -$0.10/share EPS; not catastrophic alone but compounds if insurance cycle softens or macro deteriorates.

“Does McGriff premium-multiple acquisition create or destroy value, and has market properly priced post-deal EPS trajectory? Consensus (28 Buys, 4 Holds, 0 Sells; PT $267-310) is broadly bullish but divided on timing. Bull camp argues MMC has best M&A integration track record (MMA, JLT, Dorinco), McGriff attrition will be minimal, adj. EPS pathway $12-14 by FY2028 is underappreciated. Skeptics note 3.0x leverage elevated for professional services, buybacks are paused, GAAP EPS growth deceptively slow, fiduciary income headwind real in 2026. Our PWFV analysis ($288 vs. $235) suggests bulls are right on timing — market will re-price as Thrive progresses and adj. EPS acceleration becomes undeniable in FY2026-2027 results.”

• ◆McGriff organic growth >6% FY2025/FY2026 (Q2-Q3 2026 earnings) — validates client retention and cross-sell opportunity
• ◆Thrive savings tracking ahead of $400M by FY2027 target (Q2-Q3 2026 results) — operational execution proof point
• ◆Adj. EPS guidance raised above $11.50 FY2026 (any earnings call) — de-risks consensus EPS path
• ◆Net Debt/EBITDA falls below 2.5x (Q3-Q4 2026) — unlocks $1-2B/yr buyback resumption
• ◆Insurance pricing re-hardening event (major CAT) — expands Marsh organic growth 2-3pp

• ◆McGriff broker retention below 88% — competitive threat from AJG, AON/NFP, regional independents chasing mid-market clients
• ◆Fiduciary income falls >$175M — Fed rate cuts reduce ~$497M baseline income; well-understood but material drag to FY2026 EPS
• ◆Oliver Wyman consulting cycle slowdown — macro-sensitive; 2009 precedent fell 20%; OW is 23% margin business so revenue decline flows to operating income
• ◆M&A discipline breaks — large acquisition >$3B announced while leverage >2.5x; capital allocation thesis deteriorates
• ◆McGriff integration cost overruns — experienced team has track record (MMA, JLT, Dorinco) but scale of integration unprecedented